The multigene signature MammaPrint impacts on multidisciplinary team decisions in ER(+), HER2(−) early breast cancer

BACKGROUND: Validated multigene signatures (MGS) provide additional prognostic information when evaluating clinical features of ER(+), HER2(−) early breast cancer. We have studied the quantitative and qualitative impact of MGS on multidisciplinary team (MDT) recommendations. METHODS: We prospectivel...

Descripción completa

Detalles Bibliográficos
Autores principales: Exner, R, Bago-Horvath, Z, Bartsch, R, Mittlboeck, M, Retèl, V P, Fitzal, F, Rudas, M, Singer, C, Pfeiler, G, Gnant, M, Jakesz, R, Dubsky, P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4150264/
https://www.ncbi.nlm.nih.gov/pubmed/25003667
http://dx.doi.org/10.1038/bjc.2014.339

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4150264/
https://www.ncbi.nlm.nih.gov/pubmed/25003667
http://dx.doi.org/10.1038/bjc.2014.339

Ejemplares similares